Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2023
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer
Félix Blanc-Durand, Roseline Tang, Margaux Pommier, et al.
Journal for Immunotherapy of Cancer
|
June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer
Pan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Bulletin Du Cancer
|
January 30, 2026
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer]
Cyrus Chargari, Alejandra Martinez, Judith Michels, et al.
JCI Insight
|
May 5, 2022
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants
Tala Tayoun, Vincent Faugeroux, Marianne Oulhen, et al.
Science Advances
|
September 18, 2024
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment
Carlos de la Calle-Fabregat, Josep Calafell-Segura, Margaux Gardet, et al.
Clinical Kidney Journal
|
February 13, 2019
Renal toxicities associated with pembrolizumab
Hassan Izzedine, Alexis Mathian, Stephane Champiat, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
Nature
|
August 8, 2017
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Zhan Yao, Rona Yaeger, Vanessa S Rodrik-Outmezguine, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2021
Metabolic features of cancer cells impact immunosurveillance
Adrien Joseph, Pan Juncheng, Michele Mondini, et al.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2023
Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer
Félix Blanc-Durand, Roseline Tang, Margaux Pommier, et al.
Journal for Immunotherapy of Cancer
|
June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer
Pan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Bulletin Du Cancer
|
January 30, 2026
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer]
Cyrus Chargari, Alejandra Martinez, Judith Michels, et al.
JCI Insight
|
May 5, 2022
Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants
Tala Tayoun, Vincent Faugeroux, Marianne Oulhen, et al.
Science Advances
|
September 18, 2024
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment
Carlos de la Calle-Fabregat, Josep Calafell-Segura, Margaux Gardet, et al.
Clinical Kidney Journal
|
February 13, 2019
Renal toxicities associated with pembrolizumab
Hassan Izzedine, Alexis Mathian, Stephane Champiat, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
Nature
|
August 8, 2017
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Zhan Yao, Rona Yaeger, Vanessa S Rodrik-Outmezguine, et al.
Journal for Immunotherapy of Cancer
|
June 24, 2021
Metabolic features of cancer cells impact immunosurveillance
Adrien Joseph, Pan Juncheng, Michele Mondini, et al.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
Page
of 5